Visceral leishmaniasis as an independent cause of high immune activation, T‐cell senescence, and lack of immune recovery in virologically suppressed HIV‐1‐coinfected patients von Casado, JL, Abad‐Fernández, M, Moreno, S, Pérez‐Elías, MJ, Moreno, A, Bernardino, JI, Vallejo, A

Volltext

High levels of CD4+ CTLA-4+ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis von Vallejo, A., Abad-Fernández, M., Moreno, S., Moreno, A., Pérez-Elías, M. J., Dronda, F., Casado, J. L.

Volltext

Efficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience von Martin Huertas, R., Lopez Miranda, E., Corral de la Fuente, E., Serrano Domingo, J.J., Fernandez Abad, M., Martinez, N., Guerra, E.M., Cortes Salgado, A., Gion Cortes, M., Carrato Mena, A.

Volltext

Immobilization of Proteins on Gold Surfaces von Abad, José M., Pita, Marcos, Fernández, Víctor M.

Volltext

330TiP Trastuzumab deruxtecan (T-DXd; DS-8201) in HER2-positive (HER2+) and HER2-low expressing (HER-LE) metastatic breast cancer (MBC) with brain metastases (BM) and/or leptomenin... von Vaz Batista, M., Pérez-Garcia, J.M., Llombart Cussac, A., Cortez, P., Ruiz Borrego, M., De La Haba, J., Cejalvo, J.M., Racca, F., Servitja, S., Blanch, S., Lema, L., Galàn Garmaje, M., Fernández-Abad, M., Fernández, A., Iranzo, V., González-Santiago, S., Gion, M., Nave, M., Cortés, J., Braga, S.

Volltext

Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial von Vaz Batista, M., Pérez-García, J.M., Cortez, P., Garrigós, L., Fernández-Abad, M., Gion, M., Martínez-Bueno, A., Saavedra, C., Teruel, I., Fernandez-Ortega, A., Servitja, S., Ruiz-Borrego, M., de la Haba-Rodríguez, J., Martrat, G., Pérez-Escuredo, J., Alcalá-López, D., Sampayo-Cordero, M., Braga, S., Cortés, J., Llombart-Cussac, A.

Volltext

Health perception in menopausal women von Del Sueldo, Mildren, Martell-Claros, Nieves, Abad-Cardiel, María, Zilberman, Judith M, Marchegiani, Raul, Fernández-Pérez, Cristina

Volltext

Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study von Guerrero-Zotano, Á., Pérez-García, J.M., Ruiz-Borrego, M., Bermejo, B., Gil-Gil, M., de la Haba, J., Alba Conejo, E., Quiroga, V., Carañana, V., Urruticoechea, A., Morales, S., Bellet, M., Antón, A., Fernández-Abad, M., Sánchez-Rovira, P., Calabuig, L., Pérez-Escuredo, J., Sampayo-Cordero, M., Cortés, J., Llombart-Cussac, A.

Volltext

Expression of gut-homing beta 7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients? von Abad-Fernandez, M, Gutierrez, C, Madrid, N, Hernandez-Novoa, B, Diaz, L, Munoz-Fernandez, MA, Moreno, S, Vallejo, A

Volltext

EP-1200: Partial breast irradiation and stereotactic body radiation therapy with Exactrac in breast cancer patients von Ciervide, R, Valero Albarrán, J, Garcia-Aranda, M, Lopéz Gonzalez, M, García, J.U.A.N, Sanchez Augar, E, Hernando Requejo, O, Calvo, I, Fernandez Abad, M, Rubio, M

Volltext

Risk and Return Around Bond Rating Changes: New Evidence From the Spanish Stock Market von Abad, Pilar, Robles-Fernandez, M. Dolores

Volltext

Expression of gut‐homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV‐1‐infected patients? von Abad‐Fernández, M, Gutiérrez, C, Madrid, N, Hernández‐Novoa, B, Díaz, L, Muñoz‐Fernández, MA, Moreno, S, Vallejo, A

Volltext

INCREASING NUMBER OF COMPONENTS OF THE METABOLIC SYNDROME AND CIRCULATING PROGENITOR CELL LEVELS: PP.9.257 von Abad-Cardiel, M., Villar, E., Ortega-Hernandez, A., Gomez-Garre, D., Muñoz-Pacheco, P., Avila, M., Fuentes-Ferrer, M., Fernandez-Cruz, A., Martell-Claros, N.

Volltext

188PEfficacy of trastuzumab-emtansina (T-DM1) in HER2-positive breast cancer (BC) with brain metastases (BM): A single institution experience von Martin Huertas, R, Lopez Miranda, E, Corral de la Fuente, E, Serrano Domingo, J J, Fernandez Abad, M, Martinez, N, Guerra, E M, Cortes Salgado, A, Gion Cortes, M, Carrato Mena, A

Volltext

Abstract S4-06: Biological effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+, HER2- breast cancer von Hurvitz, S, Martin, M, Fernández Abad, M, Chan, D, Rostorfer, R, Petru, E, Barriga, S, Costigan, TM, Caldwell, CW, Nguyen, T, Press, M, Slamon, D

Volltext

Metal carbide/amorphous C-based nanocomposite coatings for tribological applications von Sánchez-López, J.C., Martínez-Martínez, D., Abad, M.D., Fernández, A.

Volltext

P200 Neoadjuvant therapy in HER2+ breast cancer: Opti-HER Heart run-in phase safety data (SOLTI-1002) von Gavilá, J, Fernández-Abad, M, Pérez, J.M, Guerrero, Á.L, Oliveira, M, Llobet-Canela, M, Llombart, A

Volltext

The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients von VALLEJO, Alejandro, GUTIERREZ, Carolina, MUNOZ-FERNANDEZ, María A, MORENO, Santiago, HERNANDEZ-NOVOA, Beatriz, DIAZ, Laura, MADRID, Nadia, ABAD-FERNANDEZ, María, DRONDA, Fernando, PEREZ-ELIAS, Maria J, ZAMORA, Javier, MUNOZ, Eduardo

Volltext

Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2- breast cancer von Guarneri, V, Fasching, P A, Fernández Abad, M, García-Saenz, J A, Schneeweiss, A, Colleoni, M, Petru, E, Costigan, T M, Caldwell, C W, Barriga, S, Hurvitz, S, Slamon, D

Volltext

Oriented immobilization of Desulfovibrio gigas hydrogenase onto carbon electrodes by covalent bonds for nonmediated oxidation of H2 von RÜDIGER, Olaf, ABAD, Jose M, HATCHIKIAN, E. Claude, FERNANDEZ, Victor M, DE LACEY, Antonio L

Volltext